Shree Hari Chemicals FY26 Results & Board Approvals

Board approved audited standalone and consolidated financial statements for FY26 and Q4 FY26.
FY26 standalone net profit was ₹411.81 lakhs with EPS of ₹7.23 basic and ₹7.15 diluted.
Company declared nil deviation in preferential issue proceeds utilization for Q4 FY26.
Auditors issued unmodified opinion on both standalone and consolidated financial results.